Radiopharmaceutical therapy controls symptoms and reduces medications in insulinoma patients
Peptide receptor radionuclide therapy (PRRT) is effective for clinical control of symptomatic metastatic insulinomas, according to new research published in The Journal of Nuclear Medicine. In the largest study to date of ...
Feb 13, 2024
0
0